Davion Healthcare (DAVI) Stock Analysis

What Davion Healthcare does

Davion Healthcare Plc is an Irish public limited company that develops and commercializes non-invasive home tests for the early detection of health anomalies, including cancers. Its products use thermography: a liquid crystal film placed on the skin shows temperature differences as color shifts, and AI analysis of smartphone images interprets the result. It has four completed tests, BreastCheck, FootFlow (diabetic circulation), Testic and ThermaDerm, all non-diagnostic Class I devices. BreastCheck and FootFlow have been FDA-registered, and registered in the EU and UK, since November 2023. The company was incorporated in Cyprus in 2022 and re-domiciled to Ireland in 2024, keeping a wholly owned Cyprus subsidiary.

Key metrics

ETFs linked to DAVI

Broad-market and Healthcare sector ETFs an investor holding Davion Healthcare is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DAVI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Davion Healthcare?

Davion Healthcare trades under the ticker DAVI on NASDAQ.

Which exchange is DAVI listed on?

DAVI is listed on NASDAQ.

What sector does Davion Healthcare operate in?

Davion Healthcare is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze DAVI in a portfolio?

PortView shows DAVI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.